跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
DYPOTIN
Approved
STANDARD
DYPOTIN
NCPC Genetech Biotechnology Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c44ae2ff0f0b2fa2
Company
NCPC Genetech Biotechnology Co., Ltd
Type
Standard
Approval Details
Approval Id
c44ae2ff0f0b2fa2
Drug Approval Philippines Name
DYPOTIN
Product Name
DYPOTIN
Registration Number
BR-1216
Brand Name
DYPOTIN
Generic Name
RECOMBINANT HUMAN ERYTHROPOIETIN
Dosage Form
Solution for Injection
Dosage Strength
4000 IU/ mL (PRE-FILLED SYRINGE)
Manufacturer
NCPC Genetech Biotechnology Co., Ltd
Importer
Dynasty Pharmaceuticals
Distributor
DYNASTY PHARMACEUTICALS
Issuance Date
29 March 2022
Expiry Date
09 May 2027
Pharmacologic Category
HEMATOPOIETIC GROWTH FACTOR
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c44ae2ff0f0b2fa2
Type
Standard
Back to Philippines FDA Approvals
DYPOTIN - Philippines FDA Drug Approval Details